---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-004505"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2024-01-18T23:59:59+00:00"
generated_at: "2026-06-06T21:54:03.760144+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Adial Pharmaceuticals appoints Tony Goodman as COO effective Jan 17, 2024

## Summary
- Tony Goodman appointed COO effective Jan 17, 2024; continues as board director.
- Compensation $25k/month, must devote ≥75% business time to role.
- Will lead strategic growth, clinical development & commercial planning for AD04 (AUD treatment).
- Former Chief Business Development Officer at Indivior; helped grow addiction market revenue >$1B.
- Appointment via Statement of Work #2 under existing Master Services Agreement with The Keswick Group.

## SEC filing metadata
- accession: 0001213900-24-004505
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2024-01-18T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390024004505/0001213900-24-004505-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390024004505/ea191817-8k_adialpharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-004505
- JSON: https://secwatch.observer/filing/0001213900-24-004505.json
- Plain text: https://secwatch.observer/filing/0001213900-24-004505.txt

## Key facts
- Executive change
  Tony Goodman was appointed as Chief Operating Officer at ADIAL PHARMACEUTICALS, INC..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: Tony Goodman, a director of the Company, is the founder and principal, pursuant to which Mr. Goodman has agreed to serve in the capacity as Chief Operating Officer of the Corporation
  evidence_url: https://www.sec.gov/Archives/edgar/data/1513525/000121390024004505/0001213900-24-004505-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.